Noerr advises Formycon AG on issue of a Nordic bond

With a team led by Dr. Julian Schulze De la Cruz, Noerr has advised Formycon AG, which is listed on the SDAX of Deutsche Börse, on the issue and successful placement of an unsecured corporate bond (Nordic bond) with a total volume of EUR 70 million and a term of four years.

The bond can be increased to a total volume of up to EUR 100 million and has a variable interest rate with a margin above EURIBOR (three months). It has been placed with both institutional and private investors in Germany and abroad.

The new bonds are to be included in trading on the open market of the Frankfurt Stock Exchange and the Nordic ABM of the Oslo Stock Exchange.

The net proceeds to Formycon from the bond issue will be used to finance the further development and expansion of the biosimilar product portfolio as part of the company's growth strategy.

The Noerr team advised Formycon comprehensively on the transaction, including the preparation of the securities prospectus for the public offering and on capital market compliance issues. Noerr regularly advises Formycon on stock corporation and capital markets law and had already advised Formycon, among other things, on the uplisting to the regulated market of the Frankfurt Stock Exchange (Prime Standard) in November 2024 and on the entry of the investor Gedeon Richter via a capital increase in January 2024.

Formycon is a leading independent developer of high-quality follow-on products of biopharmaceutical drugs (biosimilars) with a focus on therapies in ophthalmology, immunology, immuno-oncology and other important indication areas.

Advisor to Formycon AG: Noerr Partnerschaftsgesellschaft mbB

Lead: Dr Julian Schulze De la Cruz (Partner, Capital Markets, Frankfurt)

Capital Markets: Dr Dominik Kloka (Partner), Dr Philip Schmoll (Associated Partner), Sebastian de Schmidt (Counsel), Dr Thomas Thies (Senior Associate), Sarah Mueller (Associate, all Frankfurt)

Finance: Dr Nikolai Warneke (Partner, Frankfurt)

Life Science: Evelyn Schulz (Partner, Dresden)

Inhouse Formycon AG: Dr Caroline Redeker (General Counsel)